Livent (LTHM) Stock Forecast, Price Target & Predictions
LTHM Stock Forecast
Livent stock forecast is as follows: an average price target of $27.33 (represents a 433.79% upside from LTHM’s last price of $5.12) and a rating consensus of 'Buy', based on 10 wall street analysts offering a 1-year stock forecast.
LTHM Price Target
The average price target for Livent (LTHM) is $27.33 based on 1-year price targets from 10 Wall Street analysts in the past 3 months, with a price target range of $30.00 to $25.00. This represents a potential 433.79% upside from LTHM's last price of $5.12.
LTHM Analyst Ratings
According to 10 Wall Street analysts, Livent's rating consensus is 'Buy'. The analyst rating breakdown for LTHM stock is 0 'Strong Buy' (0.00%), 7 'Buy' (70.00%), 3 'Hold' (30.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Livent Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| May 11, 2023 | Aleksey Yefremov | Loop Capital Markets | $30.00 | $25.60 | 17.19% | 485.94% |
| Oct 03, 2022 | Matthew DeYoe | Bank of America Securities | $27.00 | $30.07 | -10.21% | 427.34% |
| Aug 30, 2021 | David Deckelbaum | Cowen & Co. | $25.00 | $25.13 | -0.52% | 388.28% |
The latest Livent stock forecast, released on May 11, 2023 by Aleksey Yefremov from Loop Capital Markets, set a price target of $30.00, which represents a 17.19% increase from the stock price at the time of the forecast ($25.60), and a 485.94% increase from LTHM last price ($5.12).
Livent Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | - |
| Avg Price Target | - | - | - |
| Last Closing Price | $5.12 | $5.12 | $5.12 |
| Upside/Downside | -100.00% | -100.00% | -100.00% |
In the current month, the average price target of Livent stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Livent's last price of $5.12. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| May 17, 2023 | Goldman Sachs | Underperform | Buy | Upgrade |
| May 11, 2023 | Citigroup | - | Neutral | Initialise |
| May 11, 2023 | KeyBanc | - | Overweight | Upgrade |
| May 08, 2023 | CFRA | - | Buy | Upgrade |
| May 04, 2023 | CICC | - | Outperform | Upgrade |
| Apr 05, 2023 | Bank of America Securities | Neutral | Buy | Upgrade |
| Jan 11, 2023 | Exane BNP Paribas | - | Outperform | Upgrade |
| Jan 11, 2023 | Bank of America Securities | Buy | Neutral | Upgrade |
| Jan 11, 2023 | Bank of America Securities | Underperform | Buy | Upgrade |
| Jan 04, 2023 | Vertical Research | - | Buy | Upgrade |
Livent's last stock rating was published by Goldman Sachs on May 17, 2023. The company Upgrade its LTHM rating from "Underperform" to "Buy".
Livent Financial Forecast
Livent Revenue Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | $211.40M | $235.80M | $253.50M | $219.40M | $231.60M | $218.70M | $143.50M | $122.90M | $103.60M | $102.20M | $91.70M | $82.20M | $72.60M | $64.90M | $68.50M | $78.40M | $97.70M | $114.00M | $98.30M | $119.80M | $112.00M |
| Avg Forecast | $422.80M | $369.95M | $143.25M | $304.83M | $267.66M | $252.86M | $233.48M | $117.64M | $122.07M | $208.44M | $118.39M | $106.95M | $96.50M | $102.20M | $81.90M | $295.92M | $14.40M | $120.82M | $137.00M | $78.40M | $105.84M | $104.50M | $98.30M | $119.80M | $112.00M |
| High Forecast | $488.68M | $427.60M | $171.90M | $346.00M | $329.00M | $292.26M | $269.86M | $141.17M | $146.49M | $250.13M | $136.83M | $128.34M | $111.54M | $118.12M | $94.66M | $355.10M | $16.64M | $139.64M | $158.35M | $94.08M | $122.33M | $120.78M | $113.62M | $138.47M | $129.45M |
| Low Forecast | $377.06M | $329.92M | $114.60M | $285.00M | $244.00M | $225.50M | $208.22M | $94.12M | $97.66M | $166.75M | $105.58M | $85.56M | $86.06M | $91.14M | $73.04M | $236.74M | $12.84M | $107.74M | $122.18M | $62.72M | $94.39M | $93.19M | $87.66M | $106.84M | $99.88M |
| # Analysts | 2 | 2 | 4 | 7 | 10 | 9 | 9 | 18 | 13 | 12 | 8 | 10 | 9 | 6 | 6 | 12 | 9 | 8 | 9 | 16 | 7 | 7 | 8 | 13 | 8 |
| Surprise % | - | - | - | - | 0.79% | 0.93% | 1.09% | 1.86% | 1.90% | 1.05% | 1.21% | 1.15% | 1.07% | 1.00% | 1.12% | 0.28% | 5.04% | 0.54% | 0.50% | 1.00% | 0.92% | 1.09% | 1.00% | 1.00% | 1.00% |
Livent's average Quarter revenue forecast for Dec 23 based on 7 analysts is $304.83M, with a low forecast of $285.00M, and a high forecast of $346.00M. LTHM's average Quarter revenue forecast represents a 44.20% increase compared to the company's last Quarter revenue of $211.40M (Sep 23).
Livent EBITDA Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 4 | 7 | 10 | 9 | 9 | 18 | 13 | 12 | 8 | 10 | 9 | 6 | 6 | 12 | 9 | 8 | 9 | 16 | 7 | 7 | 8 | 13 | 8 |
| EBITDA | - | - | - | - | $110.60M | $100.60M | $140.60M | $91.30M | $100.00M | $93.40M | $59.00M | $23.40M | $9.00M | $10.30M | $6.60M | $3.30M | $-7.20M | $3.80M | $3.40M | $10.30M | $19.60M | $22.90M | $25.90M | $38.50M | $40.40M |
| Avg Forecast | $82.38M | $72.08M | $73.47M | $50.33M | $18.00M | $64.66M | $66.79M | $39.79M | $14.23M | $69.15M | $60.72M | $36.17M | $11.25M | $11.33M | $7.26M | $11.88M | $-45.36M | $7.07M | $4.59M | $10.30M | $21.11M | $20.82M | $25.90M | $38.50M | $40.40M |
| High Forecast | $95.21M | $83.31M | $88.17M | $60.40M | $21.60M | $77.59M | $80.15M | $47.75M | $17.08M | $82.98M | $72.86M | $43.41M | $13.50M | $13.60M | $8.71M | $14.26M | $-36.29M | $8.49M | $5.51M | $12.36M | $25.33M | $24.98M | $31.08M | $46.20M | $48.48M |
| Low Forecast | $73.46M | $64.28M | $58.78M | $40.27M | $14.40M | $51.73M | $53.43M | $31.83M | $11.38M | $55.32M | $48.58M | $28.94M | $9.00M | $9.06M | $5.81M | $9.50M | $-54.43M | $5.66M | $3.67M | $8.24M | $16.89M | $16.65M | $20.72M | $30.80M | $32.32M |
| Surprise % | - | - | - | - | 6.14% | 1.56% | 2.11% | 2.29% | 7.03% | 1.35% | 0.97% | 0.65% | 0.80% | 0.91% | 0.91% | 0.28% | 0.16% | 0.54% | 0.74% | 1.00% | 0.93% | 1.10% | 1.00% | 1.00% | 1.00% |
7 analysts predict LTHM's average Quarter EBITDA for Dec 23 to be $50.33M, with a high of $60.40M and a low of $40.27M. This is -54.49% lower than Livent's previous annual EBITDA (Sep 23) of $110.60M.
Livent Net Income Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 4 | 7 | 10 | 9 | 9 | 18 | 13 | 12 | 8 | 10 | 9 | 6 | 6 | 12 | 9 | 8 | 9 | 16 | 7 | 7 | 8 | 13 | 8 |
| Net Income | - | - | - | - | $87.40M | $90.20M | $114.80M | $82.70M | $77.60M | $60.00M | $53.20M | $7.50M | $-12.60M | $6.50M | $-800.00K | $-5.00M | $-11.80M | $-200.00K | $-1.90M | $-200.00K | $18.00M | $15.50M | $16.90M | $25.90M | $30.00M |
| Avg Forecast | $322.62M | $281.00M | $35.40M | $8.95M | $-25.20M | $43.01M | $32.19M | $7.07M | $-19.92M | $46.00M | $29.26M | $6.43M | $-15.75M | $7.15M | $-880.00K | $-18.00M | $-74.34M | $-372.31K | $-2.56M | $-200.00K | $19.38M | $14.09M | $16.90M | $25.90M | $30.00M |
| High Forecast | $359.84M | $313.43M | $42.49M | $10.73M | $-20.16M | $51.61M | $38.62M | $8.49M | $-15.94M | $55.20M | $35.11M | $7.71M | $-12.60M | $8.58M | $-704.00K | $-14.40M | $-59.47M | $-297.85K | $-2.05M | $-160.00K | $23.26M | $16.91M | $20.28M | $31.08M | $36.00M |
| Low Forecast | $279.19M | $243.18M | $28.32M | $7.16M | $-30.24M | $34.41M | $25.75M | $5.66M | $-23.91M | $36.80M | $23.41M | $5.14M | $-18.90M | $5.72M | $-1.06M | $-21.60M | $-89.21M | $-446.77K | $-3.08M | $-240.00K | $15.51M | $11.27M | $13.52M | $20.72M | $24.00M |
| Surprise % | - | - | - | - | -3.47% | 2.10% | 3.57% | 11.69% | -3.89% | 1.30% | 1.82% | 1.17% | 0.80% | 0.91% | 0.91% | 0.28% | 0.16% | 0.54% | 0.74% | 1.00% | 0.93% | 1.10% | 1.00% | 1.00% | 1.00% |
Livent's average Quarter net income forecast for Dec 23 is $8.95M, with a range of $7.16M to $10.73M. LTHM's average Quarter net income forecast represents a -89.77% decrease compared to the company's last Quarter net income of $87.40M (Sep 23).
Livent SG&A Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 4 | 7 | 10 | 9 | 9 | 18 | 13 | 12 | 8 | 10 | 9 | 6 | 6 | 12 | 9 | 8 | 9 | 16 | 7 | 7 | 8 | 13 | 8 |
| SG&A | - | - | - | - | $13.20M | $17.60M | $16.30M | $14.60M | $15.00M | $13.80M | $11.80M | $15.70M | $11.80M | $11.70M | $10.70M | $13.50M | $10.00M | $10.30M | $10.80M | $11.30M | $10.20M | $9.80M | $9.20M | $8.40M | $10.30M |
| Avg Forecast | $47.94M | $41.95M | $7.85M | $18.73M | $25.40M | $9.89M | $7.14M | $14.80M | $20.08M | $10.58M | $6.49M | $13.46M | $15.88M | $14.85M | $11.99M | $48.60M | $1.63M | $19.92M | $14.58M | $11.30M | $10.98M | $8.91M | $9.20M | $8.40M | $10.30M |
| High Forecast | $55.41M | $48.48M | $9.42M | $22.47M | $30.48M | $11.87M | $8.57M | $17.76M | $24.10M | $12.70M | $7.79M | $16.15M | $19.05M | $17.82M | $14.39M | $58.32M | $1.89M | $23.90M | $17.50M | $13.56M | $13.18M | $10.69M | $11.04M | $10.08M | $12.36M |
| Low Forecast | $42.75M | $37.41M | $6.28M | $14.98M | $20.32M | $7.91M | $5.71M | $11.84M | $16.07M | $8.46M | $5.19M | $10.77M | $12.70M | $11.88M | $9.59M | $38.88M | $1.46M | $15.93M | $11.66M | $9.04M | $8.79M | $7.13M | $7.36M | $6.72M | $8.24M |
| Surprise % | - | - | - | - | 0.52% | 1.78% | 2.28% | 0.99% | 0.75% | 1.30% | 1.82% | 1.17% | 0.74% | 0.79% | 0.89% | 0.28% | 6.12% | 0.52% | 0.74% | 1.00% | 0.93% | 1.10% | 1.00% | 1.00% | 1.00% |
Livent's average Quarter SG&A projection for Dec 23 is $18.73M, based on 7 Wall Street analysts, with a range of $14.98M to $22.47M. The forecast indicates a 41.86% rise compared to LTHM last annual SG&A of $13.20M (Sep 23).
Livent EPS Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 4 | 7 | 10 | 9 | 9 | 18 | 13 | 12 | 8 | 10 | 9 | 6 | 6 | 12 | 9 | 8 | 9 | 16 | 7 | 7 | 8 | 13 | 8 |
| EPS | - | - | - | - | $0.49 | $0.50 | $0.64 | $0.46 | $0.43 | $0.36 | $0.33 | $0.05 | $-0.08 | $0.04 | $-0.01 | $-0.03 | $-0.08 | - | $-0.01 | - | $0.12 | $0.11 | $0.12 | $0.18 | $0.21 |
| Avg Forecast | $1.54 | $1.34 | $1.58 | $0.52 | $0.48 | $0.47 | $0.39 | $1.95 | $0.40 | $0.29 | $0.14 | $1.89 | $0.02 | $0.02 | $0.01 | $0.04 | $-0.01 | $-0.00 | $0.01 | $0.05 | $0.13 | $0.11 | $0.12 | $0.23 | $0.22 |
| High Forecast | $1.72 | $1.50 | $1.76 | $0.58 | $0.53 | $0.52 | $0.43 | $2.18 | $0.45 | $0.32 | $0.16 | $2.11 | $0.03 | $0.02 | $0.01 | $0.04 | $-0.01 | $-0.00 | $0.02 | $0.06 | $0.14 | $0.12 | $0.13 | $0.26 | $0.25 |
| Low Forecast | $1.33 | $1.16 | $1.36 | $0.45 | $0.36 | $0.41 | $0.34 | $1.69 | $0.35 | $0.25 | $0.12 | $1.64 | $0.02 | $0.02 | $0.01 | $0.03 | $-0.00 | $-0.00 | $0.01 | $0.04 | $0.11 | $0.10 | $0.10 | $0.20 | $0.19 |
| Surprise % | - | - | - | - | 1.03% | 1.06% | 1.64% | 0.24% | 1.07% | 1.24% | 2.36% | 0.02% | -3.34% | 1.84% | -0.99% | -0.75% | 14.01% | - | -0.73% | - | 0.92% | 1.00% | 1.00% | 0.78% | 0.95% |
According to 7 Wall Street analysts, Livent's projected average Quarter EPS for Dec 23 is $0.52, with a low estimate of $0.45 and a high estimate of $0.58. This represents a 6.12% increase compared to LTHM previous annual EPS of $0.49 (Sep 23).
Livent Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| DNMR | Danimer Scientific | $0.30 | $0.90 | 200.00% | Hold |
| ALB | Albemarle | $76.90 | $193.85 | 152.08% | Buy |
| ALTO | Alto Ingredients | $1.43 | $3.50 | 144.76% | Buy |
| LTHM | Livent | $16.51 | $27.33 | 65.54% | Buy |
| SQM | Sociedad Química y Minera de Chile | $34.31 | $45.75 | 33.34% | Buy |
| PPG | PPG Industries | $124.78 | $162.41 | 30.16% | Buy |
| DD | DuPont de Nemours | $79.14 | $93.29 | 17.88% | Buy |
| APD | Air Products and Chemicals | $268.71 | $300.08 | 11.67% | Hold |
| LYB | LyondellBasell Industries | $93.49 | $102.47 | 9.61% | Buy |
| ECL | Ecolab | $245.05 | $240.72 | -1.77% | Buy |
| SHW | Sherwin-Williams Company | $360.83 | $340.79 | -5.55% | Buy |
| LIN | Linde | $456.85 | $424.58 | -7.06% | Buy |
LTHM Forecast FAQ
Is Livent a good buy?
Yes, according to 10 Wall Street analysts, Livent (LTHM) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 7 'Buy' recommendations, accounting for 70.00% of LTHM's total ratings.
What is LTHM's price target?
Livent (LTHM) average price target is $27.33 with a range of $25 to $30, implying a 433.79% from its last price of $5.12. The data is based on 10 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Livent stock go up soon?
According to Wall Street analysts' prediction for LTHM stock, the company can go up by 433.79% (from the last price of $5.12 to the average price target of $27.33), up by 485.94% based on the highest stock price target, and up by 388.28% based on the lowest stock price target.
Can Livent stock reach $8?
LTHM's average twelve months analyst stock price target of $27.33 supports the claim that Livent can reach $8 in the near future.
What are Livent's analysts' financial forecasts?
LTHM's analysts financial forecasts for the fiscal year (Dec 2023) are as follows: average revenue is $1.06B (high $1.24B, low $962.72M), average EBITDA is $199.79M (high $239.74M, low $159.83M), average net income is $58.94M (high $80.81M, low $37.07M), average SG&A $61.16M (high $73.39M, low $48.93M), and average EPS is $1.86 (high $2.07, low $1.55).
Did the LTHM's actual financial results beat the analysts' financial forecasts?
Based on Livent's last annual report (Dec 2022), the company's revenue was $813.2M, beating the average analysts forecast of $566.54M by 43.54%. Apple's EBITDA was $343.7M, beating the average prediction of $183.89M by 86.90%. The company's net income was $273.5M, beating the average estimation of $62.41M by 338.25%. Apple's SG&A was $55.2M, beating the average forecast of $51.95M by 6.25%. Lastly, the company's EPS was $1.59, missing the average prediction of $2.78 by -42.89%. In terms of the last quarterly report (Sep 2023), Livent's revenue was $211.4M, missing the average analysts' forecast of $267.66M by -21.02%. The company's EBITDA was $110.6M, beating the average prediction of $18M by 514.36%. Livent's net income was $87.4M, missing the average estimation of $-25.204M by -446.78%. The company's SG&A was $13.2M, missing the average forecast of $25.4M by -48.04%. Lastly, the company's EPS was $0.49, beating the average prediction of $0.478 by 2.51%